First Tracks Biotherapeutics Inc. Company Profile
NASDAQ: TRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
First Tracks Biotherapeutics at a glance
First Tracks Biotherapeutics Inc. (NASDAQ: TRAX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in San Diego, CA. First Tracks Biotherapeutics is led by Mr. Daniel R. Faga and employs about 104 people. At a market capitalization of $1.75 billion, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0002091349, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does First Tracks Biotherapeutics do?
First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States. Its products includes ANB033, a novel anti-CD122 antagonist that targets the shared beta subunit of the IL-15 and IL-2 receptors; Rosnilimab, a antibody engineered to selectively deplete pathogenic T cells in both the periphery and inflamed tissues; and ANB101, a BDCA2-modulating antibody designed to specifically target plasmacytoid dendritic cells (pDCs). First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was founded in 2019 and is based in San Diego, California.
Business description based on the company's public filings.
Company information
- Legal name
- First Tracks Biotherapeutics Inc.
- Ticker
- NASDAQ: TRAX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Daniel R. Faga
- Employees
- 104
- Headquarters
- 10770 Wateridge Circle, San Diego, CA, United States
- Phone
- 858 362 6295
- Website
- firsttracksbio.com
- Market cap
- $1.75B
- SEC CIK
- 0002091349
Companies similar to First Tracks Biotherapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| STOKStoke Therapeutics Inc. | 26.81 | -0.45% | $1.75B | vs TRAX |
| ETONEton Pharmaceuticals Inc. | 60.85 | -0.83% | $1.76B | vs TRAX |
| SDGRSchrodinger Inc. | 22.93 | -12.95% | $1.72B | vs TRAX |
| KRSAKorsana Biosciences Inc. | 37.56 | +5.95% | $1.71B | vs TRAX |
| ZYMEZymeworks Inc. | 26.14 | -2.68% | $1.81B | vs TRAX |
| MRVIMaravai LifeSciences Holdings Inc. Class A | 6.98 | -2.92% | $1.81B | vs TRAX |
| RAREUltragenyx Pharmaceutical Inc. | 16.48 | -4.30% | $1.68B | vs TRAX |
| BRVEBraveheart Bio Inc. | 20.39 | +5.81% | $1.67B | vs TRAX |